- Home
- LAZR vs MCRB Comparison
LAZR vs MCRB Comparison
Compare LAZR & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- MCRB
- Stock Information
- Founded
- LAZR 2012
- MCRB 2010
- Country
- LAZR United States
- MCRB United States
- Employees
- LAZR N/A
- MCRB N/A
- Industry
- LAZR Auto Parts:O.E.M.
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- MCRB Health Care
- Exchange
- LAZR Nasdaq
- MCRB Nasdaq
- Market Cap
- LAZR 133.4M
- MCRB 144.6M
- IPO Year
- LAZR N/A
- MCRB 2015
- Fundamental
- Price
- LAZR $2.09
- MCRB $16.89
- Analyst Decision
- LAZR Sell
- MCRB Hold
- Analyst Count
- LAZR 3
- MCRB 4
- Target Price
- LAZR $8.00
- MCRB $14.33
- AVG Volume (30 Days)
- LAZR 8.7M
- MCRB 97.8K
- Earning Date
- LAZR 11-13-2025
- MCRB 11-07-2025
- Dividend Yield
- LAZR N/A
- MCRB N/A
- EPS Growth
- LAZR N/A
- MCRB N/A
- EPS
- LAZR N/A
- MCRB 10.22
- Revenue
- LAZR $72,496,000.00
- MCRB N/A
- Revenue This Year
- LAZR N/A
- MCRB N/A
- Revenue Next Year
- LAZR $12.58
- MCRB N/A
- P/E Ratio
- LAZR N/A
- MCRB $1.65
- Revenue Growth
- LAZR N/A
- MCRB N/A
- 52 Week Low
- LAZR $1.58
- MCRB $6.53
- 52 Week High
- LAZR $18.60
- MCRB $24.67
- Technical
- Relative Strength Index (RSI)
- LAZR 51.22
- MCRB 36.96
- Support Level
- LAZR $1.87
- MCRB $17.63
- Resistance Level
- LAZR $2.37
- MCRB $18.38
- Average True Range (ATR)
- LAZR 0.24
- MCRB 1.15
- MACD
- LAZR 0.02
- MCRB -0.34
- Stochastic Oscillator
- LAZR 60.00
- MCRB 8.63
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and Advanced Technologies and Services. The majority of its revenue is generated from the Autonomy Solutions segment, which engages in the design, manufacturing, and sale of LiDAR sensors, catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries. The Advanced Technologies and Services segment provides semiconductors and related components, as well as design, test, and consulting services to the Autonomy Solutions segment and various third-party customers. Geographically, the company derives its key revenue from North America.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.